July/August 2015 Vol 8 No 5
Many private sector reports cross my desk on a regular basis, but rarely does one catch my attention as did “Ahead of the Curve: Top Ten Emerging Health Care Trends: Implications for Patients, Providers, Payers and Pharmaceuticals,” issued by the Academy of Managed Care Pharmacy (AMCP) Foundation.
Junling Wang, PhD, Ya-Chen Tina Shih, PhD, Yolanda Qin, Theo Young, BS, Zachary Thomas, MS, MBA, Christina A. Spivey, PhD, David K. Solomon, BSc, PharmD, Marie Chisholm-Burns, PharmD, MPH, MBA, FCCP, FASHP, J. Warren Salmon, PhD
In a 2013 report, the IMS Institute for Healthcare Informatics estimated that the United States spent more than $213 billion on unnecessary medical expenses as a result of irresponsible medication use.
Is It Time to Revisit Medicare Part D?
Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens
Lee Schwartzberg, MD, Brooke Harrow, PhD, Lincy S Lal, PharmD, PhD, Janna Radtchenko, MBA, Gary H. Lyman, MD, MPH
A recent Internet-based survey of hematology/oncology nurses and physicians found that 32% of healthcare providers had delayed or discontinued a patient’s chemotherapy regimen in the previous year because of CINV
Impact of Chemotherapy-Induced Nausea and Vomiting Treatment on Patient Outcomes and Resource Utilization
Results 1 - 6 of 6